In vitro studies on glucuronidation of digitoxin and its metabolites
Schmoldt, A.; Blömer, J.
Beitrage Zur Gerichtlichen Medizin 43: 149-153
1985
ISSN/ISBN: 0067-5016 PMID: 3931621 Document Number: 243076
Document emailed within 1 workday
Related Documents
Sangiah, S.; Domino, E.F. 1977: In vitro studies of some chlorpromazine metabolites as potential N-methyltransferase inhibitors Research Communications in Chemical Pathology and Pharmacology 16(2): 389-392Wiggins, J.F.; Sved, A.F.; Fernstrom, J.D. 1980: Effects of alpha-methyldopa and its metabolites on prolactin release: in vivo and in vitro studies Journal of Pharmacology and Experimental Therapeutics 212(2): 304-308
Raig, P.; Beschorner, J.; Ammon, R. 1976: Comparative studies in vivo and in vitro on the formation of phenolic biphenyl metabolites in various animal species[ Arzneimittel-Forschung 26(12): 2178-2182
Huskey, S.E.; Miller, R.R.; Chiu, S.H. 1993: N-glucuronidation reactions. I. Tetrazole N-glucuronidation of selected angiotensin II receptor antagonists in hepatic microsomes from rats, dogs, monkeys, and humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(5): 792-799
Yamazaki, H.; Shimada, T. 1998: Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(11): 1053-1057
Fisher, M.B.; Campanale, K.; Ackermann, B.L.; VandenBranden, M.; Wrighton, S.A. 2000: In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(5): 560-566
Le Bigot, J.F.; Cresteil, T.; Kiechel, J.R.; Beaune, P. 1983: Metabolism of ketotifen by human liver microsomes. In vitro characterization of a tertiary amine glucuronidation Drug Metabolism and Disposition: the Biological Fate of Chemicals 11(6): 585-589
Cohen, H.C. 1971: Digoxin and digitoxin in man: influence on rubidium transport in red blood cells in vitro Acta Cardiologica 26(5): 443-457
Huskey, S.W.; Doss, G.A.; Miller, R.R.; Schoen, W.R.; Chiu, S.H. 1994: N-glucuronidation reactions. II. Relative N-glucuronidation reactivity of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole in rat, monkey, and human hepatic microsomes Drug Metabolism and Disposition: the Biological Fate of Chemicals 22(4): 651-658
Luukkanen, L.; Mikkola, J.; Forsman, T.; Taavitsainen, P.; Taskinen, J.; Elovaara, E. 2001: Glucuronidation of 1-hydroxypyrene by human liver microsomes and human UDP-glucuronosyltransferases UGT1A6, UGT1A7, and UGT1A9: development of a high-sensitivity glucuronidation assay for human tissue Drug Metabolism and Disposition: the Biological Fate of Chemicals 29(8): 1096-1101
Kümmell, H.C.; Schreiber, K.; Kienle, G. 1982: Studies to determine individual toxic doses of digitoxin Münchener Medizinische Wochenschrift 124(22): 545-549
Tsuji, S.; Isaka, H.; Mochida, K. 1979: Studies on the dissolution test of drugs. III. Acid hydrolysis of digitoxin Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 97: 156-159
Comer, S.S.; Jasin, H.E. 1988: In vitro immunomodulatory effects of sulfasalazine and its metabolites Journal of Rheumatology 15(4): 580-586
Christians, U.; Sattler, M.; Schiebel, H.M.; Kruse, C.; Radeke, H.H.; Linck, A.; Sewing, K.F. 1992: Isolation of two immunosuppressive metabolites after in vitro metabolism of rapamycin Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(2): 186-191
Mutlib, A.E.; Chui, Y.C.; Young, L.M.; Abbott, F.S. 1992: Characterization of metabolites of xylazine produced in vivo and in vitro by LC/MS/MS and by GC/MS Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(6): 840-848
Watson, E.D. 1989: Release of immunoreactive arachidonate metabolites by equine endometrium in vitro American Journal of Veterinary Research 50(8): 1207-1209
Rieder, M.J.; Uetrecht, J.; Shear, N.H.; Cannon, M.; Miller, M.; Spielberg, S.P. 1989: Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites Annals of Internal Medicine 110(4): 286-289
Halldin, M.M.; Widman, M.; V Bahr, C.; Lindgren, J.E.; Martin, B.R. 1982: Identification of in vitro metabolites of delta 1-tetrahydrocannabinol formed by human livers Drug Metabolism and Disposition: the Biological Fate of Chemicals 10(4): 297-301
Heykants, J.; Michiels, M.; Woestenborghs, R.; Awouters, F.; Leysen, J.E.; Schuurkes, J.; Van Nueten, J.M. 1988: Pharmacokinetic evaluation of the in vitro and in vivo pharmacological profile of the major metabolites of ketanserin in the rat Arzneimittel-Forschung 38(6): 785-788
Estop, A.M.; Munné, S.; Jost, L.K.; Evenson, D.P. 1993: Studies on sperm chromatin structure alterations and cytogenetic damage of mouse sperm following in vitro incubation. Studies on in vitro-incubated mouse sperm Journal of Andrology 14(4): 282-288